ENTRY       D03656                      Drug
NAME        Darunavir (USAN/INN)
PRODUCT
  GENERIC   DARUNAVIR (Camber Pharmaceuticals)
FORMULA     C27H37N3O7S
EXACT_MASS  547.2352
MOL_WEIGHT  547.6636
CLASS       Antiviral
             DG03107  Anti-HIV agent
              DG01647  HIV protease inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      ATC code: J05AE10
            Chemical structure group: DG00659
            Product (DG00659): D03656<US> D06478<JP/US> D12637<US>
            Product (mixture): D10832<JP/US> D11382<JP/US>
EFFICACY    Antiviral, HIV protease inhibitor
TARGET      HIV protease [KO:K22599]
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION CYP inhibition: CYP3A4 [HSA:1576]
STR_MAP     map07053  Anti-HIV agents
            map07218  HIV protease inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AE Protease inhibitors
                 J05AE10 Darunavir
                  D03656  Darunavir (USAN/INN) &lt;US&gt;
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG01647  HIV protease inhibitor
                DG00659  Darunavir
                 D03656  Darunavir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00659  Darunavir
                 D03656  Darunavir
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00659  Darunavir
                 D03656  Darunavir
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                D03656  Darunavir (USAN/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03656
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03656
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG01647  HIV protease inhibitor
                DG00659  Darunavir
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00659  Darunavir
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00659  Darunavir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                DG00659  Darunavir
DBLINKS     CAS: 206361-99-1
            PubChem: 17397753
            ChEBI: 367163
            PDB-CCD: 017
            LigandBox: D03656
            NIKKAJI: J2.037.394F
ATOM        38
            1   C1y C    33.7636  -15.0281
            2   N1c N    25.3035  -15.6573
            3   C1b C    26.4921  -14.9581
            4   S4a S    24.1149  -14.9581
            5   C1c C    27.7506  -15.6573
            6   C8y C    22.8564  -15.6573
            7   C1c C    28.9392  -14.9581
            8   C1b C    28.9392  -13.5598
            9   N1b N    30.1278  -15.6573
            10  C8y C    27.7506  -12.8606
            11  C7a C    31.3164  -14.9581
            12  C8x C    26.4921  -13.5598
            13  C8x C    27.7506  -11.4622
            14  O7a O    32.5750  -15.6573
            15  O6a O    31.3164  -13.5598
            16  C8x C    25.3035  -12.8606
            17  C8x C    26.4921  -10.7631
            18  C8x C    25.3035  -11.4622
            19  C8x C    22.8564  -17.0557
            20  C8x C    21.6678  -17.7549
            21  C8y C    20.4792  -17.0557
            22  C8x C    20.4792  -15.6573
            23  C8x C    21.6678  -14.9581
            24  C1b C    25.3035  -18.1057
            25  O1a O    27.6807  -17.0557
            26  O3c O    25.0938  -13.9793
            27  O3c O    23.1361  -13.9793
            28  C1y C    35.1016  -15.4482
            29  C1y C    35.9144  -14.3276
            30  O2x O    35.0951  -13.1837
            31  C1x C    33.7471  -13.6107
            32  C1x C    35.9900  -16.5811
            33  C1x C    37.2570  -16.0851
            34  O2x O    37.2562  -14.7512
            35  N1a N    19.2207  -17.7549
            36  C1c C    26.5170  -18.7664
            37  C1a C    26.5170  -20.1664
            38  C1a C    27.7330  -18.0439
BOND        41
            1     2   3 1
            2     2   4 1
            3     3   5 1
            4     4   6 1
            5     5   7 1
            6     7   8 1 #Down
            7     7   9 1
            8     8  10 1
            9     9  11 1
            10   10  12 2
            11   10  13 1
            12   11  14 1
            13   11  15 2
            14   12  16 1
            15   13  17 2
            16   16  18 2
            17   17  18 1
            18    6  19 2
            19   19  20 1
            20   20  21 2
            21   21  22 1
            22   22  23 2
            23    6  23 1
            24    2  24 1
            25    5  25 1 #Down
            26    4  26 2
            27    4  27 2
            28    1  14 1 #Up
            29    1  28 1
            30   28  29 1
            31   29  30 1
            32   30  31 1
            33    1  31 1
            34   28  32 1
            35   32  33 1
            36   33  34 1
            37   29  34 1
            38   21  35 1
            39   24  36 1
            40   36  37 1
            41   36  38 1
///
